Analyst Ratings for ARS Pharmaceuticals Inc (SPRY)
SPRY Rating Summary
SPRY Price Target Summary
- Highest: $34.00 (Raymond James)
- Lowest: $30.00 (Roth/MKM)
- Average: $32.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$32.00 (+253.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$32.00 (+253.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/4/2025 | Roth/MKM | Kyle Bauser | New Coverage | Buy (N/A) |
30.00 (N/A) |
8.62 (9.06) |
5.1% | Details |
| 3/7/2025 | Scotiabank | Louise Chen | New Coverage | Sector Outperform (N/A) |
30.00 (N/A) |
10.79 (9.06) |
-16.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
